Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Journal of the American Heart Association|May 28, 2024
Review of the Ticagrelor Trials Evidence BaseGrace C Herron, Eric R BatesExpert Review of Cardiovascular Therapy|May 21, 2004
Bivalirudin: an anticoagulant option for percutaneous coronary interventionEric R BatesAnnals of Internal Medicine|August 18, 2020
Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent anginaEric R BatesAnnals of Internal Medicine|August 18, 2020
In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 yearsEric R BatesAnnals of Internal Medicine|December 1, 2025
P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic eventsEric R Bates, Annals of Internal Medicine|May 6, 2024
In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 moEric R BatesCurrent Cardiology Reports|July 3, 2007
New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarctionEric R BatesAnnals of Internal Medicine|January 3, 2022
In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 moEric R BatesAnnals of Internal Medicine|December 1, 2025
After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomesEric R Bates, Pageof 11